1 Chen W,Zheng R,Zeng H,et al.Annual report on status of cancer in China,2011[J].Chin J Cancer Res,2015,27(1):2-12. 2 Hu L,Duan YT,Li JF,et al.Biglycan enhances gastric cancer invasion by activating FAK signaling pathway[J].Oncotarget,2014,5(7):1885-1896. 3 Zhu YH,Yang F,Zhang SS,et al.High expression of biglycan is associated with poor prognosis in patients with esophageal squamous cell carcinoma[J].Int J Clin Exp Pathol,2013,6(11):2497-2505. 4 Gu X,Ma Y,Xiao J,et al.Up-regulated biglycan expression correlates with the malignancy in human colorectal cancers[J].Clin Exp Med,2012,12(3):195-199. 5 Fisher LW,Heegaard AM,Vetter U,et al.Human biglycan gene.Putative promoter,intron-exon junctions,and chromosomal localization[J].J Biol Chem,1991,266(22):14371-14377. 6 Ward M,Ajuwon KM.Regulation of pre-adipocyte proliferation and apoptosis by the small leucine-rich proteoglycans,biglycan and decorin[J].Cell Prolif,2011,44(4):343-351. 7 Zaidi AH,Gopalakrishnan V,Kasi PM,et al.Evaluation of a 4-protein serum biomarker panel-biglycan,annexin-A6,myeloperoxidase,and protein S100-A9(B-AMP)-for the detection of esophageal adenocarcinoma[J].Cancer,2014,120(24):3902-3913. 8 Yamamoto K,Ohga N,Hida Y,et al.Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells[J].Br J Cancer,2012,106(6):1214-1223. 9 王惠文,刘瑞宝,刘岩,等.乙肝病毒感染性肝癌经TACE后Caspase-3与FAK的表达及意义[J].实用肿瘤学杂志,2011,25(1):49-52. 10 Yan LM,Wang CZ,Lin B,et al.Lewis y enhances CAM-DR in ovarian cancer cells by activating the FAK signaling pathway and upregulating Bcl-2/Bcl-XL expression[J].Biochimie,2015,113(1):17-25. 11 Zang M,Zhang Y,Zhang B,et al.CEACAM6 promotes tumor angiogenesis and vasculogenic mimicry in gastric cancer via FAK signaling[J].Biochim Biophys Acta,2015,1852(5):1020-1028. |